+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Western Blotting Market - Growth, Trends, and Forecasts (2020 - 2025)

  • PDF Icon


  • 110 Pages
  • June 2020
  • Region: Global
  • Mordor Intelligence
  • ID: 4896024
UP TO OFF until Sep 30th 2023
The western blotting market is majorly driven by factors such as the rising burden of chronic diseases across the globe, growing research activities in the biotech and pharma sector, and raised R&D investment done by pharmaceutical and biotechnology companies.

Western blotting is a widely known and used test that is used in cell and molecular biology. With the help of this test, one can detect the specific type of protein from the complex mixture of proteins that is extracted from the cell. This test has gained attraction in the market due to its specificity, low cost, and ease of use.

Despite the technique that has been evolved since its inception, there have been several advancements in this technique that occurred in the last decade. Introduction of capillary and microfluidic platforms is one of the advancements which has helped immensely in reducing the time taken for test and decreased the sample requirements along with enabling high-throughput capabilities. Hence, owing to the certain characteristics of the western blot test, the market is believed to witness considerable growth over the forecast period.

Key Market Trends

Disease Diagnostic Segment will be Witnessing a Healthy CAGR Over the Forecast Period

Western blot test is having a wide range of applications in medical diagnostics. For the diagnosis of diseases such as BSE (Bovine Spongiform Encephalopathy), FIV (Feline Immunodeficiency Virus), HBV (Hepatitis B Virus) infection, Lyme Disease among others.

Generally, this test is used as a confirmatory test for the above-mentioned diseases after the ELISA test is done with a positive result. For Lyme Disease, US FDA has suggested the two-tier protocol using an ELISA test initially and then the specific western blot tets for the confirmation of diagnosis if the results of ELISA are positive.

Previously, western blotting was commonly done to confirm the HIV diagnosis. However, the Centre for Disease Control and Prevention (CDC) in the year has recommended discontinuing the Western blot test for HIV as there are novel techniques that came up in the market for HIV detection. Furthermore, studies have suggested that western blot is a priority test for the diagnosis of diseases such as BSE (Bovine Spongiform Encephalopathy), and FIV (Feline Immunodeficiency Virus). Hence, owing to the significance of this test in the disease diagnosis, it is indicated that this segment will be witnessing a healthy CAGR over the forecast period.

North America is Expected to Dominates the Western Blotting Market

The global market for western blotting is dominated by the North America region and the United States holds the largest share of this market. The prime factor contributing to the large share in the United States is the developed healthcare system and the presence of key players in the country.

Companies such as Bio-Rad, Thermo Fisher Scientific, etc are having an active presence in the US market and due to the adaptable nature of US population towards the novel products or technologies, companies are able to establish their novel product launches in the United States which is helping the market studied to grow in this region.

Competitive Landscape

The major players are having competition among themselves for the market share and with the rising application of this test and growing pharmaceutical and biotechnology industries, it is believed that few small to mid-sized companies will penetrate the market soon and hold a substantial share in the market. The major market players operating in the western blotting market include Danaher Corporation, Thermofisher Scientific, Biorad laboratories, Perklin Elmer and Merck KgaA among others

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Proteomics Market Across the Globe
4.2.2 Increasing R&D Investment by the Pharma and Biotech Companies
4.2.3 Wide Applications of the Western Blot Test
4.3 Market Restraints
4.3.1 Availability of the Alternatives for Western Blot
4.3.2 Accuracy Issues
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Product
5.1.1 Instruments Gel Electrophoresis Instruments Blotting Systems Imagers Chemiluminescent Imagers Fluorescent Imagers Others
5.1.2 Consumables Reagents Kits
5.2 By Application
5.2.1 Biomedical & Biochemical Research
5.2.2 Disease Diagnostics
5.2.3 Others
5.3 By End-User
5.3.1 Academia and Research Institutes
5.3.2 Diagnostic Centers
5.3.3 Others
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
5.4.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Bio-Rad Laboratories, Inc.
6.1.2 Thermo Fisher Scientific, Inc.
6.1.3 LI-COR Biosciences
6.1.4 Bio-Techne Corporation
6.1.5 Merck KGaA
6.1.6 PerkinElmer, Inc.
6.1.7 Cell Signaling Technology
6.1.8 Advansta, Inc.
6.1.9 Danaher Corporation

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • LI-COR Biosciences
  • Bio-Techne Corporation
  • Merck KGaA
  • PerkinElmer, Inc.
  • Cell Signaling Technology
  • Advansta, Inc.
  • Danaher Corporation